A Bioinformatics-Based Study on Methylation Alterations of the FBLN1 Gene in Hippocampal Tissue of Alzheimer’s Disease Model DKO and DTG Mice
Open Access
- 20 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 9036
Abstract
Alzheimer’s disease (AD) is characterized by progressive cognitive decline and late-stage neurobehavioral issues marked by amyloid-beta plaques and Tau protein tangles. This study aims to investigate Fibulin-1(FBLN1) gene expression in the hippocampal tissue of Presenilin-1/Presenilin-2 conditional double-knockout (DKO) and double-transgenic (DTG) mice, using single-cell sequencing and experimental methods to verify abnormal methylation status and correlation with AD. Genomic DNA from DKO and DTG mice was used for genotyping. Reduced Representation Bisulfite Sequencing (RRBS) identified 10 genes with abnormal methylation changes, with protein–protein interaction (PPI) analysis highlighting five core genes, including FBLN1. Single-cell sequencing, RT-PCR, and Western blotting (WB) were used to analyze FBLN1 mRNA and protein levels in the hippocampal tissues of early-stage and mid-stage AD DKO, DTG, and CBAC57 mice. RRBS identified 10 genes with abnormal methylation, with PPI highlighting five core genes. Single-cell sequencing showed significant FBLN1 expression in AD groups. RT-PCR and WB indicated elevated FBLN1 mRNA and protein levels in mid-stage AD DKO and DTG mice compared to CBAC57 mice, with no differences in early-stage AD DKO and CBAC57 mice. RRBS revealed hypomethylation of the FBLN1 gene in mid-stage AD DKO mice. Elevated FBLN1 expression in AD models suggests an age-dependent neurodegenerative mechanism independent of amyloid-beta deposition. This study enhances our understanding of AD’s epigenetic mechanisms, which will aid targeted diagnosis, treatment, and prognosis.Keywords
Funding Information
- Joint Research Fund for Sichuan Province Science and Technology Agency and Southwest Medical University of China (14JC0161, 2011204, 2021SYF28)
- Scientific Research Starting Foundation for Doctors of Southwest Medical University of China (14JC0161, 2011204, 2021SYF28)
- the Fund for Luzhou Science and Technology Bureau of Sichuan Province of China (14JC0161, 2011204, 2021SYF28)
This publication has 51 references indexed in Scilit:
- Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseAlzheimer's & Dementia, 2022
- Targeting the blood-brain barrier for the delivery of stroke therapiesAdvanced Drug Delivery Reviews, 2021
- Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's diseaseAlzheimer's & Dementia, 2020
- Epigenetics in Alzheimer’s Disease: Perspective of DNA MethylationMolecular Neurobiology, 2017
- Tau Biology and Tau-Directed Therapies for Alzheimer’s DiseaseDrugs, 2016
- The role of components of the extracellular matrix and inflammation on oral squamous cell carcinoma metastasisArchives of Oral Biology, 2014
- Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapyAgeing Research Reviews, 2013
- Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanomaTumor Biology, 2013
- Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinomaMolecular Carcinogenesis, 2011
- Loss of presenilin function causes Alzheimer's disease‐like neurodegeneration in the mouseJournal of Neuroscience Research, 2008